Taru Blom, MD, PhD

Experienced people and change leader based in Finland, advising on pharma R&D programs, organizational design, leadership, and capability building in global, multicultural environments. Coaching-oriented and human-centric leadership approach, known for strategic clarity, sound judgment, and effective engagement with executive teams, boards, and external stakeholders.

Physician executive (MD, PhD) with over 30 years of experience advising and leading pharmaceutical R&D and medical organizations across big pharma and biotech in Europe and also in the US. Clinical and scientific foundation built with the thesis on endocrinology and gynecology and continued in Leiras/Schering Ag and a biotech Hormos Medical.  Thereafter, more than two decades in senior leadership roles at Orion Pharma, including Vice President of R&D and Chief Medical Officer, providing CMO-level medical, clinical, and R&D leadership.

Extensive advisory and hands-on experience across the full drug development lifecycle, from translational and early clinical development through global Phase I–III programs, late development, regulatory affairs, and global medical affairs. Trusted advisor on clinical development strategy, portfolio prioritization, governance models, and operating structures across oncology, CNS, respiratory, critical care, and animal health portfolios. Latest two years working hands on with insomnia in CNS area and cell therapies in oncology, along with her R&D management, organisation leadership and portfolio duties.

Strong track record in initiating, supporting and governing complex partnerships, licensing collaborations, and joint development programs, including Phase III alliances. Recognized for operational excellence in clinical development models, outsourcing and CRO strategies, contracting frameworks, negotiations, and financial and resource governance.